Rift Valley fever virus (RVFV) is a mosquito-transmitted virus causing mortality among farm animals. It is one of the 8 pathogens of the World Health Organisation list of top-emerging diseases that are likely to cause major epidemics. The virus is currently circulating on the continent of Africa but is also a risk for other continents including Europe.
Wageningen Bioveterinary Research developed a live-weakened vaccine that is optimally designed for safety and effectiveness. The vaccine will be further developed together with the industry to achieve effective control of Rift Valley fever.